MARCELA ALVAREZ-LAZO: Open Payments
NPI 1477095305 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 24 payments from 11 companies in 2025. Trend: 2023 $1,458 · 2024 $2,062 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $283 |
| Axsome Therapeutics, Inc. | 3 | $262 |
| ABBVIE INC. | 2 | $250 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Biogen, Inc. | 1 | $120 |
| Lilly USA, LLC | 1 | $117 |
| PFIZER INC. | 1 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Alkermes, Inc. | 2 | $30 |
Products named: Auvelity, VRAYLAR, ABILIFY MAINTENA, REZDIFFRA, ZURZUVAE, KISUNLA, REXULTI, COMIRNATY.
Industry payments across FL — which companies pay providers there.
